$2.82
0.051.81%
Last update: 3:20 PM
15 minutes delayed
Heron Therapeutics
HRTXNASDAQ
Heron Therapeutics (NASDAQ:HRTX) Stock, Guidance And Forecast
Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 05/07/2024 | HRTX | Heron Therapeutics | FY | 2024 | — | — | — | $138.00M | $158.00M | $144.87M | Get Alert |
| 03/12/2024 | HRTX | Heron Therapeutics | FY | 2024 | — | — | — | $138.00M | $158.00M | $139.10M | Get Alert |
| 11/14/2023 | HRTX | Heron Therapeutics | FY | 2023 | — | — | — | $123.00M | $125.00M | $124.61M | Get Alert |
| 11/14/2023 | HRTX | Heron Therapeutics | FY | 2024 | — | — | — | $138.00M | $158.00M | $156.57M | Get Alert |
| 11/08/2022 | HRTX | Heron Therapeutics | FY | 2022 | — | — | — | $93.00M | $95.00M | $107.14M | Get Alert |
| 08/09/2022 | HRTX | Heron Therapeutics | FY | 2022 | — | — | — | $93.00M | $95.00M | $106.69M | Get Alert |
FAQ
What is the most recent guidance for Heron Therapeutics (HRTX)?
There have been no specific sales or earnings guidance reported for Heron Therapeutics in recent months.
Browse guidance and forecast on all stocks.